Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | XRTX XORTX Therapeutics Inc. - Common | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.73 +2.4% | $15.90 -2.5% |
| StockIQ Score | 25F Weak Risk: High | 41D Weak Risk: High |
| Technical | 15F | 36F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 44D | 50C- |
| Quality | — | 50C- |
| Risk | 34F | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
XORTX Therapeutics has a significantly lower investor score (25) compared to Ascentage Pharma (41), indicating weaker investor sentiment. Ascentage also outperforms with a technical score of 36 versus XORTX’s 15, showing stronger short-term market trends. Both carry a "WEAK" rating, but Ascentage provides additional data points for deeper analysis.
